Ultra-Short Circulating Tumor DNA (usctDNA) in Plasma and Saliva of Non-Small Cell Lung Cancer (NSCLC) Patients is a research paper published in Cancers (2020). On theSindex it has a DataRank of 0. It has been cited 47 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R21 CA239052
National Institutes of Health
Grant: UH3 TR000923
National Institutes of Health
Grant: UH2 CA206126
National Institutes of Health
Grant: U01 CA233370
NCI NIH HHS
Grant: U24 CA086368
NCI NIH HHS
Grant: U01 CA086368
NCI NIH HHS
Grant: UH3 CA206126
National Institutes of Health
Grant: 5U01CA233370-03
EFIRM-Liquid Biopsy (eLB): Ultrasensitive ctDNA and miRNA Detection for Early Assessment of Lung Cancer
National Institutes of Health
Grant: 1R21CA239052-01
Ultra-short circulating tumor DNA (uctDNA) for liquid biopsy of non-small cell lung cancer
National Institutes of Health
Grant: 5UH3TR000923-04
Clinical Utility of Salivary ExRNA Biomarkers for Gastric Cancer Detection
National Institutes of Health
Grant: 5UH2CA206126-02
Advancing EFIRM-Liquid Biopsy (eLB) to a CLIA-Certified Laboratory Developed Test (eLB-LDT) for Detection of Actionable EGFR Mutations in NSCLC Patients
FWCI
2.19
Citation Percentile
0.9%
Influential Citations
1
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals